Northwest Biotherapeutics and the UK National Health Service Blood and Transplant Announce Collaboration to Support DCVax®-L Production

Summary

Northwest Biotherapeutics announced a collaboration with the UK National Health Service Blood and Transplant to support production of DCVax-L, a personalized immune therapy for solid tumor cancers.